Jagomast T, Finck J, Tangemann-Munstedt I, Auth K, Dromann D, Franzen K
Online J Public Health Inform. 2024; 16:e57718.
PMID: 39626237
PMC: 11653046.
DOI: 10.2196/57718.
Lima F, Leite Martins L, Szklo A
Epidemiol Serv Saude. 2023; 32(4):e2023708.
PMID: 38126544
PMC: 10741305.
DOI: 10.1590/S2237-96222023000400004.en.
Cunningham J, Schell C, Godinho A
Perspect Public Health. 2023; 143(4):193-195.
PMID: 37589324
PMC: 10467010.
DOI: 10.1177/17579139221136720.
Tas D, Uneri O
Eurasian J Med. 2023; 55(1):14-19.
PMID: 36861860
PMC: 10081098.
DOI: 10.5152/eurasianjmed.2021.21058.
Ciechanowski K, Banasik-Jemielniak N, Jemielniak D
Curr Psychol. 2022; :1-13.
PMID: 36248218
PMC: 9553632.
DOI: 10.1007/s12144-022-03826-0.
Global monitoring of public interest in preventive measures against COVID-19 via analysis of Google Trends: an infodemiology and infoveillance study.
Ito T
BMJ Open. 2022; 12(8):e060715.
PMID: 35953258
PMC: 9378949.
DOI: 10.1136/bmjopen-2021-060715.
Seasonal Patterns and Trends in Dermatoses in Poland.
Klimiuk K, Krefta D, Kolkowski K, Flisikowski K, Sokolowska-Wojdylo M, Balwicki L
Int J Environ Res Public Health. 2022; 19(15).
PMID: 35897306
PMC: 9330858.
DOI: 10.3390/ijerph19158934.
When Patients Recover From COVID-19: Data-Driven Insights From Wearable Technologies.
Guo M, Nguyen L, Du H, Jin F
Front Big Data. 2022; 5:801998.
PMID: 35574570
PMC: 9096352.
DOI: 10.3389/fdata.2022.801998.
Substance, use in relation to COVID-19: A scoping review.
Kumar N, Janmohamed K, Nyhan K, Martins S, Cerda M, Hasin D
Addict Behav. 2021; 127:107213.
PMID: 34959077
PMC: 8684053.
DOI: 10.1016/j.addbeh.2021.107213.
Effect of COVID-19 on smoking cessation outcomes in a large primary care treatment programme: an observational study.
Veldhuizen S, Selby P, Wong B, Zawertailo L
BMJ Open. 2021; 11(8):e053075.
PMID: 34446503
PMC: 8392738.
DOI: 10.1136/bmjopen-2021-053075.
Effectiveness and Acceptance of a Smartphone-Based Virtual Agent Screening for Alcohol and Tobacco Problems and Associated Risk Factors During COVID-19 Pandemic in the General Population.
Auriacombe M, Fournet L, Dupuy L, Micoulaud-Franchi J, De Sevin E, Moriceau S
Front Psychiatry. 2021; 12:693687.
PMID: 34335332
PMC: 8322524.
DOI: 10.3389/fpsyt.2021.693687.
COVID-19 and the Manoeuvres of the Tobacco Industry.
Mihaltan F, Rajnoveanu A, Rajnoveanu R
Maedica (Bucur). 2021; 16(1):75-79.
PMID: 34221159
PMC: 8224717.
DOI: 10.26574/maedica.2020.16.1.77.
The impact of the coronavirus (COVID-19) pandemic on the development of obsessive-compulsive symptoms in Saudi Arabia.
Alateeq D, Almughera H, Almughera T, Alfedeah R, Nasser T, Alaraj K
Saudi Med J. 2021; 42(7):750-760.
PMID: 34187919
PMC: 9195531.
DOI: 10.15537/smj.2021.42.7.20210181.
Smoking, distress and COVID-19 in England: Cross-sectional population surveys from 2016 to 2020.
Kock L, Brown J, Shahab L, Moore G, Horton M, Brose L
Prev Med Rep. 2021; 23:101420.
PMID: 34150478
PMC: 8193154.
DOI: 10.1016/j.pmedr.2021.101420.
Epidemics, Public Sentiment, and Infectious Disease Equity Market Volatility.
Meng J, Su Q, Zhang J, Wang L, Xu R, Yan C
Front Public Health. 2021; 9:686870.
PMID: 34055733
PMC: 8160087.
DOI: 10.3389/fpubh.2021.686870.
Did the COVID-19 Pandemic Spark a Public Interest in Pet Adoption?.
Ho J, Hussain S, Sparagano O
Front Vet Sci. 2021; 8:647308.
PMID: 34046443
PMC: 8145284.
DOI: 10.3389/fvets.2021.647308.
Impact of Smoking on Women During the Covid-19 Pandemic.
Mihaltan F, Rajnoveanu A, Rajnoveanu R
Front Med (Lausanne). 2021; 8:584061.
PMID: 33996840
PMC: 8119742.
DOI: 10.3389/fmed.2021.584061.
Decreased public awareness of skin cancer during the coronavirus pandemic.
Heerfordt I
Int J Dermatol. 2021; 60(9):e334-e335.
PMID: 33982801
PMC: 8239598.
DOI: 10.1111/ijd.15659.
The psychological impact of the COVID-19 pandemic on adults and children in the United Arab Emirates: a nationwide cross-sectional study.
Saddik B, Hussein A, Albanna A, Elbarazi I, Al-Shujairi A, Temsah M
BMC Psychiatry. 2021; 21(1):224.
PMID: 33941119
PMC: 8090921.
DOI: 10.1186/s12888-021-03213-2.
Use of alcohol, tobacco, cannabis, and other substances during the first wave of the SARS-CoV-2 pandemic in Europe: a survey on 36,000 European substance users.
Manthey J, Kilian C, Carr S, Bartak M, Bloomfield K, Braddick F
Subst Abuse Treat Prev Policy. 2021; 16(1):36.
PMID: 33902668
PMC: 8072737.
DOI: 10.1186/s13011-021-00373-y.